Drug Information

Drug General Information
Drug ID
D06RPY
Former ID
DNC004853
Drug Name
2-[4-(1-Ethyl-propyl)-piperazin-1-yl]-quinoline
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527370]
Structure
Download
2D MOL

3D MOL
Formula
C18H25N3
Canonical SMILES
CCC(CC)N1CCN(CC1)C2=NC3=CC=CC=C3C=C2
InChI
1S/C18H25N3/c1-3-16(4-2)20-11-13-21(14-12-20)18-10-9-15-7-5-6-8-17(15)19-18/h5-10,16H,3-4,11-14H2,1-2H3
InChIKey
FNSKLNDKQPXTIL-UHFFFAOYSA-N
PubChem Compound ID
11314275
Target and Pathway
Target(s) Histamine H3 receptor Target Info Inhibitor [527370]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Histamine receptors
G alpha (i) signalling events
WikiPathways Monoamine Transport
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 527370J Med Chem. 2005 Jan 13;48(1):306-11.2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
Ref 527370J Med Chem. 2005 Jan 13;48(1):306-11.2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.